Arcadia vs Innovaccer (2026)
The AI Health Index reads this as a choice about how much of the work a health system wants its vendor to perform, because both platforms are the data foundation an organisation buys to run risk contracts. Arcadia has stayed a data and analytics company: integration across more than fifty electronic health record systems resolved through its own master patient index, Medicare claims benchmarks with the provenance named, and validation from the National Committee for Quality Assurance that data flowing through the platform is fit to be scored on, with its first generative product only now arriving. Innovaccer is becoming an operator: five acquisitions have added live health coaches, revenue cycle services and payer utilisation management, and the Centers for Medicare and Medicaid Services has accepted it as a participant in a federal care model rather than only a supplier to participants. Choose Arcadia where the requirement is a validated data foundation and the buyer brings or builds the intelligence on top. Choose Innovaccer where breadth and current independent validation decide, provided the buyer establishes which capabilities are production proven in its own setting. Neither publishes a price, names a base model, or publishes any bias testing. One thing a buyer should know: the documented failure mode in claims based risk scoring is silent, a patient scored too low is simply never contacted and no incident ever surfaces, so the one question to ask both vendors is what the risk models predict and whether subgroup performance has been measured.
- Arcadia's clinical data holds the Certified Data Partner designation in the National Committee for Quality Assurance Data Aggregator Validation programme and a separate Validated Data Stream designation covering HEDIS measurement, meaning an external body examined whether the data itself is fit to be scored on. The AI Health Index records no equivalent third party validation of the data artefact on Innovaccer's record.
- Arcadia's security record was tested by someone else: top ratings in every category of an independent cybersecurity preparedness evaluation run by KLAS Research and Censinet, an exercise roughly ten percent of eligible vendors agreed to enter, alongside ISO 27001 held since 2017 and HITRUST CSF certification since 2020. The AI Health Index reads Innovaccer's published security wording as ambiguous between holding its own certifications and operating inside a customer's certified environment.
- Arcadia remains a supplier rather than a programme participant, so a buyer's performance data does not sit with a vendor whose own results are at stake in the same federal models its customers compete in. The AI Health Index regards that separation as a point Innovaccer can no longer claim.
- In the 2026 Best in KLAS awards Innovaccer took the top score in three categories at once, Gravity at 93.2 for provider analytics against a market average of 83.9, Galaxy at 90.5 for payer analytics and Cured at 90.1 for customer relationship management, drawn from validated customer interviews rather than vendor submissions. The AI Health Index records no current independent performance validation of that breadth for Arcadia.
- Innovaccer states single tenant deployment inside the customer's own cloud with the position that no protected health information leaves the customer's control, which the AI Health Index grades as the strongest deployment disclosure in its category. Arcadia's published material names its cloud but leaves tenancy, residency and continuity unanswered.
- Through the Story Health and CaduceusHealth acquisitions Innovaccer now fields live health coaches working with remote biometric monitoring and a United States based revenue cycle services team serving nearly 4,000 providers, so a buyer can purchase operated services alongside software. The AI Health Index records Arcadia as selling the platform while the buyer runs the work.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Arcadia and Innovaccer are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Arcadia | Innovaccer |
|---|---|---|
| Primary category | Value Based Care Intelligence | Health System AI Platforms |
| Founded | Not recorded | 2014 |
| Headquarters | Boston, Massachusetts, United States | San Francisco, California |
| Website | arcadia.io | innovaccer.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Arcadia its top capability grade on EHR and Interoperability Depth. Set against Innovaccer, Arcadia grades higher on Autonomy and Oversight Model and Security Certifications and Trust Center. Its thinnest published disclosure sits on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and AI Governance and Bias Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Innovaccer its top capability grade on several axes, including Clinical and Operational Evidence, EHR and Interoperability Depth and Deployment Model and Data Residency. Set against Arcadia, Innovaccer grades higher on several axes, including AI Centrality, Model and Technology Transparency and Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Arcadia or Innovaccer?
On the axes where the AI Health Index separates them, Arcadia grades higher on Autonomy and Oversight Model and Security Certifications and Trust Center, and Innovaccer grades higher on several axes, including AI Centrality, Model and Technology Transparency and Model Supply Chain Disclosure. Innovaccer leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Arcadia and Innovaccer differ most?
The widest separation the AI Health Index records between Arcadia and Innovaccer is on Deployment Model and Data Residency, where Arcadia grades C and Innovaccer grades A. That axis sits in the Integration and Deployment group, so it should carry the most weight for a buyer whose binding constraint is how the product lands in the stack already in place.
Where do Arcadia and Innovaccer grade the same?
The AI Health Index grades Arcadia and Innovaccer the same on HIPAA and BAA Posture, FDA and Regulatory Status and EHR and Interoperability Depth. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Arcadia and Innovaccer not disclosed?
At the last review, at least one of Arcadia and Innovaccer published thin or absent detail on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and AI Governance and Bias Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Health System AI Platforms page.
Neither vendor publishes a price of any kind, so the AI Health Index can tell a reader what each platform discloses but not what either costs, and implementation, the cost third party buyer guidance flags as the principal risk in this category, is equally unpublished by both.
Neither names the base model behind its generative products, publishes per model accuracy, or publishes any bias testing, in a product category where a widely cited study documented claims based risk stratification underestimating illness in Black patients.
Arcadia's headline outcome figures, 81 percent in visit diagnosis capture, 59 percent more closed risk per patient and a 24 percent reduction in inpatient admissions, carry no denominator, time period or method, and its most recent public security report is a SOC 2 Type One with certification dates now several years old.
Innovaccer's own material leaves a training tension unreconciled, a platform described as continuously trained on real world healthcare data alongside a statement that no protected health information leaves the customer's control, and nothing published describes how its participation in a federal care model is separated from serving customers who compete in it.
Demand the unit of charge and implementation cost from both, the training data reconciliation and the conflict separation from Innovaccer, and a current SOC 2 Type Two and the arithmetic behind the outcome claims from Arcadia.